Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
about
XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma riskCurrent Data on Risk Factor Estimates Does Not Explain the Difference in Rates of Melanoma between Hispanics and Non-Hispanic WhitesCutaneous Melanoma in AsiansMultiple complementary transcripts of pCMa1, a novel gene located at chromosome 11p15.1-2, and melanocytic cell transformation.Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients.The value of sunscreens.Living a "shady life": sun-protective behaviour for Canadians.Tumor progression, early diagnosis and prognosis of melanoma.Immune and gene therapy for melanoma, and the immunobiology of melanoma.Melanoma genetics and the development of rational therapeutics.Factors associated with inconsistent sun protection in first-degree relatives of melanoma survivors.The genetics of hereditary melanoma and nevi. 1998 update.Development of a melanoma risk prediction model incorporating MC1R genotype and indoor tanning exposure: impact of mole phenotype on model performance.Low rates of clinical recurrence after biopsy of benign to moderately dysplastic melanocytic nevi.A place in the shade: reducing the risks of UV exposure.Cigarette smoking and malignant melanoma: a case-control study.Strategies for early melanoma detection: Approaches to the patient with neviResveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB.Sunbeds and sunlamps: who used them and their risk for melanoma.Histopathological characteristics of small diameter melanocytic naevi.Melanoma epidemiology.Telomerase activity in melanocytic lesions: A potential marker of tumor biology.Prevalence and predictors of recent skin examination in a population-based twin cohort.Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.Combined risk factors for melanoma in a Mediterranean populationMelanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.Dysplastic nevi and melanomaThe dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management.The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspectsThe molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia.Melanoma survival in the United States, 1992 to 2005.Correlation between dermoscopic and histopathological diagnoses of atypical nevi in a dermatology outpatient clinic of the Medical School of São José do Rio Preto, SP, Brazil.A melanoma risk score in a Brazilian population.Study of Nevi in Children (SONIC): baseline findings and predictors of nevus countA polymorphism in the agouti signaling protein gene is associated with human pigmentation.Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families."Better do not touch" and other superstitions concerning melanoma: the cross-sectional web-based survey.Incidence of atypical nevi in Olmsted County: an epidemiological study.Pediatric melanoma: a review.Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?
P2860
Q23909400-E498ADD8-883E-4E3A-9829-E566FC253AE5Q26752438-6718AB77-D1C7-4553-888E-B97724281C01Q28078576-ECD83FF7-0C61-4E5A-A0E1-B181C3DA2442Q31107689-10024C93-949B-424C-A880-52CB597D62ECQ33533679-14F02B2D-1462-45B0-9EF9-B19A87F0A889Q33587459-77B6179F-4735-465F-8136-9C7963C20867Q33649027-BB42EE3C-DAC7-4983-A182-EF18AAF7C011Q33700535-40520844-9D6C-4B79-B77F-0F0FF357E711Q33706946-CE9B121E-33D1-4AEC-AEB9-BB17D04879A8Q33726956-632D61D1-50E5-4C1F-8275-89AD2EF43624Q33752951-40B7E35A-31E0-4921-BACD-BBE584CB1FAFQ33813969-3D775484-EF00-4216-8833-BCBC921D0DB7Q33863654-5BDD49FF-386C-4C36-960E-B5F473B10B56Q33917739-541964FF-66ED-4F38-9485-B5CFDA13FD4EQ34024711-53015F7C-2BB5-43DA-96A5-2A590E43BD88Q34075591-5827BDE3-5F9F-45B6-B5B2-D2EB97E4E8A4Q34606851-FECC5AD2-CE72-444E-A280-B59215ADAC89Q34917495-EE104D3A-954B-4AB1-83DC-9FBB96239C1DQ35021042-1DE12B17-3BA9-4DBF-9225-3AAEF53B3242Q35586833-D8883978-ADFE-4BC5-9DBF-44AD3EBCCDF4Q35602637-7237770D-6A83-44C3-AAF2-5BC1BECBE7FAQ35809940-3A0A1E77-A267-448B-AF36-CB746E2E177CQ35920808-CCB3C7C9-4CE3-4341-B1DE-90D331787BE8Q36109510-EC28C1EB-AA2F-49F8-8EF9-BFC556E517CEQ36643944-D0AEB1AC-B90E-4DB9-A4BF-9E9E3019B9EEQ36712918-A93EE2CC-DC75-4D04-A68E-36D778A45F6BQ36739933-854B1FA4-8405-4A6D-AA25-1E8982C8CDA6Q36752192-246EF5EF-1161-4C3B-87A6-1E43DB75E3B9Q36762792-0B1CE210-245F-448E-8B05-7512643B4739Q36798179-3D85B503-3B1D-4FA3-9DFD-6F54FEED4495Q36961188-80AB52AD-589C-4767-823F-0BC7315B7428Q37114264-98DEECE6-11B2-4C9F-989B-249580D36B5DQ37114285-2FD33F49-6BBE-443F-A028-626BA626A8C6Q37288866-025A0FC8-8D9D-4199-8377-F399BED5E549Q37361476-2EB76D2F-8099-4FF4-80B0-22100872DA16Q37415242-B827F148-72BE-4D24-9E45-659D14244877Q37416290-2431C436-C518-4788-921D-102F687D0136Q37483960-B8E4E6B8-83E3-4426-9B80-E2A71EC50D1BQ37531855-714FCAA4-E7A5-43C4-A890-DFFD71892A0DQ37615286-A0063203-8B4A-491F-9069-D7A817653C90
P2860
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
@en
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
@nl
type
label
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
@en
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
@nl
prefLabel
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
@en
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
@nl
P2093
P1476
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
@en
P2093
M A Tucker
R W Sagebiel
P304
P356
10.1001/JAMA.1997.03540420035026
P407
P577
1997-05-01T00:00:00Z